NanoVibronix, Inc. (NASDAQ:NAOV) Sees Large Decline in Short Interest

NanoVibronix, Inc. (NASDAQ:NAOV) was the recipient of a large drop in short interest in November. As of November 15th, there was short interest totalling 86,200 shares, a drop of 50.9% from the October 31st total of 175,700 shares. Currently, 2.3% of the shares of the stock are sold short. Based on an average daily volume of 176,100 shares, the days-to-cover ratio is presently 0.5 days.

NanoVibronix Trading Up 3.0 %

Shares of NAOV stock opened at $0.73 on Thursday. NanoVibronix has a twelve month low of $0.46 and a twelve month high of $1.52. The company has a market capitalization of $2.74 million, a price-to-earnings ratio of -0.59 and a beta of 1.51. The firm has a 50-day moving average price of $0.61 and a 200 day moving average price of $0.67.

NanoVibronix Company Profile

NanoVibronix, Inc, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.